Company Quick10K Filing
Medicine Man Technologies
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-03
10-K 2017-12-31 Filed 2018-03-27
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-17
10-Q 2017-03-31 Filed 2017-05-16
10-Q 2017-03-31 Filed 2017-05-16
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-12
8-K 2020-06-19
8-K 2020-06-05
8-K 2020-06-01
8-K 2020-05-20
8-K 2020-05-12
8-K 2020-04-29
8-K 2020-04-20
8-K 2020-02-25
8-K 2020-02-25
8-K 2020-02-24
8-K 2020-02-24
8-K 2020-02-20
8-K 2019-12-10
8-K 2019-12-09
8-K 2019-11-23
8-K 2019-11-11
8-K 2019-10-21
8-K 2019-09-16
8-K 2019-09-09
8-K 2019-09-09
8-K 2019-09-06
8-K 2019-09-02
8-K 2019-08-31
8-K 2019-08-30
8-K 2019-08-29
8-K 2019-08-28
8-K 2019-08-15
8-K 2019-08-14
8-K 2019-08-06
8-K 2019-07-15
8-K 2019-06-06
8-K 2019-06-05
8-K 2019-05-24
8-K 2019-05-15
8-K 2019-04-26
8-K 2019-03-14
8-K 2019-02-28
8-K 2019-01-10
8-K 2018-12-03
8-K 2018-12-01
8-K 2018-09-17
8-K 2018-07-17
8-K 2018-06-25

Medicine Man Technologies Financials

MDCL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Axim Biotechnologies (AXIM) 45,833 18% -9.2 -211% 2,377 8,554 513 95 -5,011 -4,838 44,666
Hickok (HICKA) 45,489 22% 4.7 11% 62,836 43,919 89,731 19,505 6,620 10,751 50,895
PayMeOn (PAYM) 45,400 -1,762% -13.7 -131% 2,583 3,294 4 -69 -3,373 -3,295 45,135
Arch Therapeutics (ARTH) 45,130 -9.4 -157% 2,902 3,710 0 0 -4,548 -4,548 42,950
Positive Physicians Holdings (PPHI) 44,543 0% 148.2 -0% 154,581 81,735 20,883 0 -474 174 25,856
Intersections (INTX) 44,437 68% 4.2 25% 37,736 36,881 155,171 105,871 9,357 13,535 56,883
Petroshare (PRHR) 44,347 0% 5.6 -15% 36,928 45,101 16,134 0 -5,501 7,311 40,589
Medicine Man Technologies (MDCL) 44,094 40% -2.1 -38% 35,919 7,979 9,100 3,629 -13,562 -13,517 28,889
Terra Tech (TRTC) 44,034 50% -2.4 -23% 129,806 38,597 25,337 12,769 -29,554 -23,775 57,216
Hoth Therapeutics (HOTH) 44,012 -10.7 -88% 4,335 25 0 0 -3,793 -3,793 40,597
Cosmos Holdings (COSM) 43,856 7% 120.0 -1% 21,280 27,665 36,392 2,689 -183 380 45,596
Gulfslope Energy (GSPE) 43,691 -3.7 -45% 30,784 31,113 0 0 -13,724 -11,439 42,552
Solis Tek (SLTK) 43,678 51% -25.8 -163% 1,378 6,785 1,895 973 -2,244 -1,693 43,612
Where Food Comes From (WFCF) 43,107 42% 21.1 4% 19,538 6,989 15,075 6,341 759 1,882 39,712
CCUR (CCUR) 42,638 0% 7.9 6% 65,998 9,965 5,021 0 4,245 4,508 35,471
Smartag International (SMRN) 42,619 100% -140.1 -347% 87 31 1 1 -304 -304 42,532
Mastermind (MMND) 42,338 88% 91.3 16% 2,419 256 3,727 3,297 375 459 41,906
Newgioco (NWGI) 42,058 0% -17.6 -21% 25,358 17,927 25,127 0 -5,400 -2,117 37,352
Parallax Health Sciences (PRLX) 41,922 280% -5.4 -333% 2,373 7,209 82 229 -7,914 -7,871 42,507
Sanuwave Health (SNWV) 41,781 42% -5.8 -467% 1,644 14,962 693 290 -7,680 -7,149 41,378

Balance Sheet ($'000)2015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash39526227138923521612019287493838495303227004,34715,205
Accounts Receivable84151325253582313574614721,2751,0091,1812991,8111,901
Inventory1098810610668442489372533408
PP&E545454545465135200219232241216216244246251251
Assets5304774482954547289937,44011,35711,13210,84512,02421,00718,22217,76421,36535,919
Accounts Payable2934900032441234220172203661757916
Long-Term Debt
Liabilities18224791681,1041,00579996139380772731,1482,4167,7387,979
Stockholders' Equity512455401285285-376-126,64110,39610,73910,76511,94620,73417,07415,34813,62727,940
Income Statement ($'000)2015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue241235200150237465418829283481,2111,7004,6472,0031,7585,339
Cost of Revenue368813744831971652722975683743804591,5991,0862,786
Gross Profit20614762106153-1513768336316108381,2444,1884056712,553
R&D
SG&A14913711419894-23195341332635322102202351454719
Tax0-200000
Net Income50-47-114-10019-1,270111-4,402-486-512256934,951-2,912-8,823-1,828
Cash Flow ($'000)2015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1709-233-96-421-31-316-17-299-5594,941374-1,107-3,946
Cash Investing-30300021-84101-29-6725-5,261-152-90-397
Cash Financing000150660-75255-13301,00001574,84515,200